Dutch Life Sciences conference’s Post

Exciting times ahead! LCC is transitioning from a seasoned CRO to a fully-fledged biotech company, harnessing its validated, automated PACE chemistry platform to drive its innovative project pipeline. https://lnkd.in/eS5KMfnh

We are pleased to announce that LCC is transitioning from a CRO into a hub-and-spoke biotech company. Our focus will be on generating small molecule lead candidate assets against oncology and rare disease targets. On behalf of all the team, we would like to offer our gratitude to everyone who has supported us along our journey. There are too many to name, but thank you to our investors - Deepbridge Capital, Praetura Ventures, and Maven Capital Partners - who have been with us during the last 10 years and are continuing to support us moving forward; the University of Liverpool, our collaborators, our clients, legal teams, past colleagues, and everyone else we have worked with. Read the full announcement on our new website, which was excellently put together by Mal MacKenzie and the team: https://lnkd.in/eint4FTZ

If you or anyone you know is looking for some lab space to jumpstart your research, please reach out! ABI Lab is the place to be ✨ If you don’t believe me, check out this most recent news letter by MetroWest Daily News!

The Calibr-Skaggs Institute for Innovative Medicines, a nonprofit research institute founded by Scripps Research President and CEO Peter Schultz, joined Scripps Research in 2018 as its drug discovery division. As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise. Learn more: https://ow.ly/xl0F50UtCCV

This summarizes the essence of our Life Science fund. We invest in life saving science.

Check out a great network on New Product Planning in Biopharma! Our latest forum discussion was focused on the evolving role NPP plays in driving strategy not only at the program level but also in shaping franchise and corporate strategy through transversal leadership. Through the discussion I was humbled to learn how much the industry has evolved. With accelerated paths to market, biomarkers, companion diagnostics, and increasing demand for health economics outcomes measures, NPP plays an increasingly important strategic role for shaping future success in #drugdevelopment. Huge shout out to Mike Conlon, Alexander Brown and Chad Faulkner for making it such a dynamic and engaging forum. If you’re interested in more forums like this - check out the content below and sign up for future forums! #biotech #newproductplanning #pharma #strategy https://lnkd.in/eTJqQKtg

Unlock the truth behind Peptides and Human Cellular Tissue Products in this comprehensive virtual masterclass. Get ready to revolutionize your practice with the All Things Peptides Virtual Masterclass! Happening June 7-8, this event is packed with insights, strategies, and practical applications in peptides and advanced biologics. Why Attend? * Access Recordings: Can’t make it live? All ticket holders get access to recordings of all sessions, presentation slides, and event materials. * Comprehensive Knowledge: Dive deep into peptides and advanced biologics with practical implementation strategies. * Empowerment & Growth: MedMasters aims to educate and empower you with resources to deliver superior therapies, revolutionizing patient outcomes and opening doors to new revenue streams. Don’t miss out! Secure your spot now and elevate your practice. Learn More: https://lnkd.in/ecQzyDFM

Huge thank you to the NJNY RAPS chapter leadership team - Timothy Kline, Ph.D., RAC, Madhuri Jerfy, M.S., RAC, Lopa Bakrania, PhD, RAC, and Irwin A. Ruderfer, CPC; our RAC workshop facilitators - Rubab Haque, RAC (US), Karen Zimm, Sangeeta Dey, PhD, RAC and Alka Kamra as well as our speakers Alexander Gaffney, MS, RAC, Laura DiAngelo, Cassandra T. San Jose, MS, RAC, PMP, SCPM, Nicholas Langevin, Josh Coulter, Dominique Lagrave, Priti Shah, Cynthia Ban, Francesca Mangia, David Mukanga, Debra Yeskey, Pharm.D., Claire Harrison, Agnes Yeboah, Wendy Corbett, Eric Bleickardt, Candice McCoy, Yogita Bahl, Brittany Dustman, PharmD, MS, RAC and Matt Campagna for a great 2024! Our 2025 schedule is being finalized. Look for a Winter/Spring speed networking event (our 2018 event sold out) and a full day onsite CMC workshop in Central NJ on May 16. Other onsite and virtual events are being planned. Reach out if there is a specific topic you would like to see presented. FOLLOW us at https://lnkd.in/ePPHaD9S Here's our 2024 list: Virtual 2024 Educational Webinars 17 January "FDA 2024 Forecast" 13 March "The Art of Submission Planning: From Strategy to Filing" 11 April "Maximizing the Impact of Patient Experience Data in Regulatory Decision-Making" 13 November "Revolutionizing Regulatory Collaboration: Discover the Power and Potential of Reliance" Onsite Events 04 June BMS/Celgene "Navigating Regulatory Challenges related to Lifecycle Management of Cell Therapy Products" 26 October RAC Global Drugs All day workshop (Temple University) #RAPS #Chapter #Webinars #RAC

Are you in the Life Sciences Eco-system and in the GTA? Here is an event to look into!

Excited for these new developments in the clinical trial space! #Cytek #FullSpectrumProfiling (FSP) technology allows for more insights in clinical trials. Let’s discuss how we can work more closely with your group at #CYTO2024 this week